Tweedy, Browne Co LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tweedy, Browne Co LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$9,668,144
+99643.6%
94,916
-1.2%
0.52%
+1.6%
Q2 2023$9,693
+7.7%
96,056
-1.8%
0.51%
+3.9%
Q1 2023$9,000
+0.3%
97,828
-1.1%
0.49%
+2.5%
Q4 2022$8,973
-99.9%
98,906
-1.8%
0.48%
+41.8%
Q3 2022$7,655,000
-8.0%
100,709
+2.3%
0.34%
-0.9%
Q2 2022$8,320,000
-7.0%
98,430
-3.4%
0.34%
+17.6%
Q1 2022$8,945,000
-3.6%
101,938
-3.9%
0.29%
-1.7%
Q4 2021$9,280,000
+2.1%
106,089
-4.6%
0.29%
-3.3%
Q3 2021$9,092,000
-13.6%
111,180
-3.7%
0.30%
+2.7%
Q2 2021$10,529,000
-3.5%
115,403
-9.6%
0.30%
-6.9%
Q1 2021$10,916,000
-11.0%
127,704
-1.6%
0.32%
-16.5%
Q4 2020$12,260,000
+0.7%
129,832
-7.3%
0.38%
-19.3%
Q3 2020$12,176,000
-3.3%
140,023
-2.8%
0.47%
-6.0%
Q2 2020$12,588,000
+0.7%
144,121
-4.9%
0.50%
-13.4%
Q1 2020$12,500,000
-14.2%
151,610
-1.4%
0.58%
+10.3%
Q4 2019$14,563,000
+8.0%
153,795
-0.9%
0.53%
+10.3%
Q3 2019$13,482,000
-7.3%
155,140
-2.6%
0.48%
-7.2%
Q2 2019$14,542,000
-7.4%
159,259
-2.5%
0.51%
-0.8%
Q1 2019$15,710,000
+6.4%
163,404
-5.0%
0.52%
-1.0%
Q4 2018$14,763,000
-5.1%
172,040
-4.7%
0.52%
+11.5%
Q3 2018$15,561,000
+11.4%
180,607
-2.3%
0.47%
+8.1%
Q2 2018$13,968,000
-7.9%
184,913
-1.5%
0.43%
-6.7%
Q1 2018$15,170,000
-4.3%
187,636
-0.6%
0.46%
+6.9%
Q4 2017$15,847,000
-6.3%
188,746
-4.2%
0.44%
-5.4%
Q3 2017$16,908,000
+3.1%
196,952
+0.3%
0.46%
-5.5%
Q2 2017$16,395,000
+7.8%
196,422
-4.1%
0.49%
+11.4%
Q1 2017$15,207,000
-3.6%
204,747
-5.5%
0.44%
-11.4%
Q4 2016$15,776,000
-9.2%
216,590
-1.6%
0.49%
-5.7%
Q3 2016$17,380,000
-9.9%
220,115
-5.8%
0.52%
-3.3%
Q2 2016$19,289,000
+12.0%
233,783
-1.6%
0.54%
+14.1%
Q1 2016$17,216,000
-17.4%
237,664
-1.9%
0.47%
-22.5%
Q4 2015$20,839,000
-9.0%
242,201
-2.7%
0.61%
-10.3%
Q3 2015$22,890,000
-8.4%
249,022
-2.0%
0.68%
-1.3%
Q2 2015$25,000,000
-2.6%
254,217
-2.3%
0.69%
-0.3%
Q1 2015$25,660,000
+4.1%
260,217
-2.2%
0.69%
+9.8%
Q4 2014$24,651,000
-7.8%
266,037
-6.3%
0.63%
+2.6%
Q3 2014$26,731,000
+2.2%
283,983
-1.7%
0.62%
+10.2%
Q2 2014$26,147,000
+5.5%
288,825
-0.9%
0.56%
-2.3%
Q1 2014$24,783,000
+5.5%
291,500
-0.3%
0.57%
+4.6%
Q4 2013$23,498,000
+3.7%
292,340
-1.0%
0.55%
+0.2%
Q3 2013$22,652,000
+8.2%
295,290
-0.3%
0.54%
+4.2%
Q2 2013$20,937,000296,0950.52%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders